Publications by authors named "A Wedell"

Aberration of mitochondrial function is a shared feature of many human pathologies, characterised by changes in metabolic flux, cellular energetics, morphology, composition, and dynamics of the mitochondrial network. While some of these changes serve as compensatory mechanisms to maintain cellular homeostasis, their chronic activation can permanently affect cellular metabolism and signalling, ultimately impairing cell function. Here, we use a Drosophila melanogaster model expressing a proofreading-deficient mtDNA polymerase (POLγ) in a genetic screen to find genes that mitigate the harmful accumulation of mtDNA mutations.

View Article and Find Full Text PDF

Background: The identification of a heterozygous exonic GGC repeat expansion in ZFHX3 underlying spinocerebellar ataxia type 4 (SCA4) has solved a 25-year diagnostic conundrum. We used adaptive long-read sequencing to decipher the pathogenic expansion in the index Utah family and an unrelated family from Iowa of Swedish ancestry. Contemporaneous to our discovery, other groups identified the same repeat expansion in affected individuals from Utah, Sweden, and Germany, highlighting the current pivotal time for detection of novel repeat expansion disorders.

View Article and Find Full Text PDF

BACKGROUNDMitochondrial diseases belong to the group of inborn errors of metabolism (IEM), with a prevalence of 1 in 2,000-5,000 individuals. They are the most common form of IEM, but, despite advances in next-generation sequencing technologies, almost half of the patients are left genetically undiagnosed.METHODSWe investigated a cohort of 61 patients with defined mitochondrial disease to improve diagnostics, identify biomarkers, and correlate metabolic pathways to specific disease groups.

View Article and Find Full Text PDF
Article Synopsis
  • Spinocerebellar ataxia 4 (SCA4) is an adult-onset neurodegenerative disorder linked to chromosome 16q22.1, characterized by ataxia, polyneuropathy, and various neurological symptoms that were previously poorly understood.* -
  • A research study on three Swedish families employed various diagnostic methods, including genetic testing and neuroimaging, revealing new features such as dysautonomia, motor neuron involvement, and significant brain atrophy.* -
  • The study identified a novel genetic mutation, a GGC expansion in the ZFHX3 gene, as the cause of SCA4, expanding its clinical profile to include symptoms like dysautonomia and other neuromuscular
View Article and Find Full Text PDF